New advances in type 1 diabetes

In table 3 in this review by Subramanian and colleagues (BMJ 2024;384:e075681, doi:10.1136/bmj-2023-075681, published 26 January 2024), the time in range target for most adults with type 1 diabetes has been corrected to >70%. The article and PDF have been updated.

Source link

  • Share this post

Leave a Comment